Cases & Deals

Guided Therapeutics issues $2.6 million of Convertible Preferred Stock and Warrants in private placement

Clients Guided Therapeutics, Inc

Jones Day advised Guided Therapeutics, Inc., a medical device company developing a biophotonic cancer detection testing platform, in connection with a $2.6 million private placement to accredited investors of Convertible Preferred Stock and Warrants to purchase shares of Common Stock.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.